Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-003109
Filing Date
2025-04-07
Accepted
2025-04-07 21:54:15
Documents
1
Period of Report
2025-04-03

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7799
  Complete submission text file 0001641172-25-003109.txt   9521
Mailing Address C/O IMPRIMIS PHARMACEUTICALS, INC 12264 EL CAMINO REAL, SUITE 350 SAN DIEGO CA 92130
Business Address
BAUM MARK L (Reporting) CIK: 0001274282 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35814 | Film No.: 25820016

Mailing Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN
Business Address 1A BURTON HILLS BLVD SUITE 200 NASHVILLE TN 615.733.4731
HARROW, INC. (Issuer) CIK: 0001360214 (see all company filings)

EIN.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)